These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6982238)

  • 41. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemopoietic colonies: in vitro cloning of normal and leukemic cells.
    Metcalf D
    Recent Results Cancer Res; 1977; (61):Title page, 1-227. PubMed ID: 143701
    [No Abstract]   [Full Text] [Related]  

  • 43. Abolition of suppressive effect of acute myeloid leukemia cells on normal granulocyte-macrophage colony formation induced by interleukin-5 associated with eosinophilic cell induction.
    Motoji T; Okada M; Takanashi M; Oshimi K; Mizoguchi H
    Leuk Lymphoma; 1995 Jun; 18(1-2):171-8. PubMed ID: 8580822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of different normal hematopoietic regulatory proteins in the differentiation of myeloid leukemic cells.
    Lotem J; Shabo Y; Sachs L
    Int J Cancer; 1988 Jan; 41(1):101-7. PubMed ID: 3257207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocytic colony-stimulating factor (G-CSF) does not induce differentiation of WEHI3B(D+) cells but is required for the survival of the mature progeny.
    Böhmer RM; Burgess AW
    Int J Cancer; 1988 Jul; 42(1):53-8. PubMed ID: 2455692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Growth inhibition by thymidine of leukemic HL-60 and normal human myeloid progenitor cells.
    Akman SA; Ross DD; Rosen H; Salinger C; Andrews PA; Chou FE; Bachur NR
    Cancer Res; 1981 Jun; 41(6):2141-6. PubMed ID: 6940654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells.
    Chiu CP; Lee F
    J Immunol; 1989 Mar; 142(6):1909-15. PubMed ID: 2784140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction by recombinant human granulocyte colony-stimulating factor of differentiation of mouse myeloid leukemic M1 cells.
    Tomida M; Yamamoto-Yamaguchi Y; Hozumi M; Okabe T; Takaku F
    FEBS Lett; 1986 Oct; 207(2):271-5. PubMed ID: 3490401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coupling of growth and differentiation in normal myeloid precursors and the breakdown of this coupling in leukemia.
    Lotem J; Sachs L
    Int J Cancer; 1983 Jul; 32(1):127-34. PubMed ID: 6602779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro growth characteristics of virally transformed murine myeloid cells.
    Nooter K; Bentvelzen P
    Cancer Res; 1976 Apr; 36(4):1246-50. PubMed ID: 177204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitization of resistant myeloid leukemia clone cells by anti-cancer drugs to factor-stimulating differentiation.
    Hayashi M; Okabe J; Hozumi M
    Gan; 1979 Apr; 70(2):235-8. PubMed ID: 313889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective regulation by hydrocortisone of induction of in vivo differentiation of myeloid leukemic cells with granulocyte-macrophage colony-stimulating factor, interleukin 6 and interleukin 1 alpha.
    Lotem J; Sachs L
    Leukemia; 1992 May; 6(5):426-31. PubMed ID: 1593907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth and differentiation of a murine interleukin-3-producing myelomonocytic leukemia cell line in a protein-free chemically defined medium.
    Kajigaya Y; Ikuta K; Sasaki H; Matsuyama S
    Leukemia; 1990 Oct; 4(10):712-6. PubMed ID: 1699090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells.
    Shabo Y; Lotem J; Sachs L
    Leukemia; 1989 Dec; 3(12):859-65. PubMed ID: 2685477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of normal differentiation of myeloid leukemic cells. IV. Induction of differentiation by serum from endotoxin treated mice.
    Fibach E; Sachs L
    J Cell Physiol; 1974 Apr; 83(2):177-85. PubMed ID: 4595662
    [No Abstract]   [Full Text] [Related]  

  • 56. Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells.
    Metcalf D
    Leukemia; 1989 May; 3(5):349-55. PubMed ID: 2469911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of in vivo differentiation of myeloid leukemic cells. III. Regulation by T lymphocytes and inflammation.
    Lotem J; Sachs L
    Int J Cancer; 1983 Dec; 32(6):781-91. PubMed ID: 6606629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
    Katagiri T; Miyazawa K; Nishimaki J; Yaguchi M; Kawanishi Y; Ohyashiki K
    Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of factors stimulating differentiation of mouse myeloid leukemia cells from a Yoshida sarcoma cell line cultured in serum-free medium.
    Hozumi M; Umezawa T; Takenaga K; Ohno T; Shikita M; Yamane I
    Cancer Res; 1979 Dec; 39(12):5127-31. PubMed ID: 315274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell differentiation and malignancy.
    Sachs L
    Cell Biophys; 1986 Dec; 9(1-2):225-42. PubMed ID: 2436796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.